[ad_1]
The American company ARCA biopharma has added new hope to a drug that treats the virus that has killed large numbers of people around the world.
He said that he is awaiting official approvals from the United States Food and Drug Administration (FDA) to begin the stages of clinical trials, which he hopes to achieve before the end of 2020.
A possible treatment for the coronavirus will give a dose of hope amid the pandemic that has killed nearly a million people and infected 31 million people.
The medicine is called “AB201”.
The drug was tested in its early stages in 700 patients.
The drug is based on what is known as “precision medicine to develop genetically modified therapies.”
It is a protein that develops from DNA.
The drug acts as a suppressor of tissues that could become infected with the virus and limits its spread to them.
The drug stimulates or modifies the immune capacity to have antiviral properties and reduces the appearance of serious infections that increase the activity of the virus and stimulate its spread.
The drug may have the ability to treat diseases caused by viruses and organized by DNA.
This approach is based on developing drugs and treatments according to the genetic composition of the human being, and identifying the similar characteristics of a group of them to know the effect of the drug on them, which is frequently used in treatments for cardiovascular and vascular diseases. lung disease, high cholesterol and depression, according to the Mayo Clinic website.
Relative developments based on genetic testing are still being developed, and it is estimated that more than 200 drugs contain an information leaflet on biomarkers for pharmacogenetics.
In developing these drugs, researchers rely on “genomic” data from individuals using a specific drug, which will show the effect of DNA similarity on response to treatments.
Through the pre-testing of these drugs, the risks of side effects are found, if it is safe or not, what is the best dose to achieve the desired result and for how long it should be used.
On the other hand, the race to find a vaccine is accelerating and nine of these vaccines are in the final stage or are preparing to be in the last stage.
This drug is similar in some of the methods being developed for vaccines, as some laboratories rely on DNA and stimulate the immune system to produce artificial copies of the virus protein to recognize and fight it.
As of now, there are no specific treatments for diseases caused by Corona, but people are generally given medications to relieve symptoms caused by the virus.
Source: Alhurra
